BioForm Dermal Filler PMAs Up For FDA Panel Review In August
This article was originally published in The Gray Sheet
Executive Summary
BioForm Medical's premarket approval applications for a dermal filler intended to treat both run-of-the-mill wrinkles and HIV-related facial fat loss will be reviewed by FDA's General & Plastic Surgery Devices Panel Aug. 24
You may also be interested in...
FDA Approves BioForm’s Radiesse Dermal Filler For HIV, Cosmetic Indications
BioForm says it will likely go public within the next year following approval of its Radiesse dermal filler for the cosmetic treatment of nasolabial folds and facial wasting in patients with HIV
FDA Approves BioForm’s Radiesse Dermal Filler For HIV, Cosmetic Indications
BioForm says it will likely go public within the next year following approval of its Radiesse dermal filler for the cosmetic treatment of nasolabial folds and facial wasting in patients with HIV
Radiesse Dermal Filler Gets Two Approval Recommendations From FDA Panel
BioForm Medical's Radiesse dermal filler device went two for two Aug. 24, with an FDA advisory panel recommending approval of the product both as a treatment for abnormal facial fat loss in people with HIV and as a cosmetic remedy for facial wrinkles